Details for Patent: 10,039,718
✉ Email this page to a colleague
Which drugs does patent 10,039,718 protect, and when does it expire?
Patent 10,039,718 protects EVOTAZ, PREZCOBIX, SYMTUZA, GENVOYA, STRIBILD, and TYBOST, and is included in six NDAs.
Protection for GENVOYA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has ninety patent family members in thirty-three countries.
Summary for Patent: 10,039,718
| Title: | Use of solid carrier particles to improve the processability of a pharmaceutical agent |
| Abstract: | The invention provides a composition comprising, a compound of formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof and a plurality of solid carrier particles, as well as methods for using the composition to inhibit the activity of cytochrome P-450. |
| Inventor(s): | Koziara; Joanna M. (Foster City, CA), Menning; Mark M. (Foster City, CA), Strickley; Robert G. (Foster City, CA), Yu; Richard (Foster City, CA), Kearney; Brian P. (Foster City, CA), Mathias; Anita A. (Foster City, CA) |
| Assignee: | Gilead Sciences, Inc. (Foster City, CA) |
| Application Number: | 12/434,513 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,039,718 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 10,039,718
International Family Members for US Patent 10,039,718
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 3089 | ⤷ Try a Trial | |||
| African Regional IP Organization (ARIPO) | 3250 | ⤷ Try a Trial | |||
| Argentina | 075369 | ⤷ Try a Trial | |||
| Australia | 2009242451 | ⤷ Try a Trial | |||
| Australia | 2010210598 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
